References

Revised 18 May 2012

  1. Ornish, D., Weidner, G., Fair, W.R., et al. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 2005 Sep;174(3):1065-9; discussion 9-70.
  2. Bill-Axelson, A., Holmberg, L., Ruutu, M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 2011 May 5;364(18):1708-17.
  3. Widmark, A., Klepp, O., Solberg, A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009 Jan 24;373(9660):301-8.
  4. Wilt, T. Initial results of the Prostate Cancer Intervention Versus Observation Trial (PIVOT), American Urology Association Annual Meeting; 2011; Washington DC; 2011.
  5. Hugosson, J., Carlsson, S., Aus, G., et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010 Aug;11(8):725-32.
  6. Schroder, F.H., Hugosson, J., Roobol, M.J., et al. Prostate-cancer mortality at 11 years of follow-up. N. Engl. J. Med. 2012 Mar 15;366(11):981-90.
  7. Andriole, G.L., Crawford, E.D., Grubb, R.L., 3rd, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J. Natl. Cancer Inst. 2012 Jan 18;104(2):125-32.
  8. Pickles, T., Group, S.A.. PSA Toolkit: PSA screening and testing for prostate cancer: Canadian Partnership Against Cancer; 2009.
  9. Lilja, H., Ulmert, D., Bjork, T., et al. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. J. Clin. Oncol. 2007 Feb 1;25(4):431-6.
  10. Wolf, A.M., Wender, R.C., Etzioni, R.B., et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. C.A. Cancer J. Clin. 2010 Mar-Apr;60(2):70-98.
  11. BC Cancer Agency. Cancer Management Guidelines. Prostate Cancer: Management: Low Risk. 2007.
  12. BC Cancer Agency. Cancer Management Guidelines. Prostate Cancer: Management: Intermediate Risk. 2007.